MedTrace Logo

Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

NCT00876616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 362

Last updated 2013-08-29

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy and safety of multi-target therapy in the treatment of class Ⅲ,Ⅳ,Ⅴ,Ⅲ+Ⅴand Ⅳ+Ⅴ lupus nephritis.

Conditions

Interventions

DRUG

Tacrolimus+Mycophenolate mofetil

FK506 4mg/d,MMF 1.0g/d

DRUG

Cyclophosphamide

CTX 0.75g/m2 BSA

Sponsors & Collaborators

  • Ruijin Hospital

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • RenJi Hospital

    collaborator OTHER

  • China Medical University, China

    collaborator OTHER

  • Huashan Hospital

    collaborator OTHER

  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER

  • Beijing Friendship Hospital

    collaborator OTHER

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Zhi-Hong Liu, M.D.

    lead OTHER

Principal Investigators

  • Zhihong Liu, Master · Nanjing University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-05-31
Completion
2012-02-29

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00876616 on ClinicalTrials.gov